<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url>
<loc>https://www.diabesityrounds.com</loc>
<lastmod>2026-11-16T22:32:57.31659+00:00</lastmod>
<changefreq>hourly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/archive</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/about</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/editorial-policy</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/advisory-board</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/corrections</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/disclosures</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/privacy</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/subscribe</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/follow</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/compare</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/india-prices</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/ask</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/ask/answers</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/journal-club</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/quiz</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/listen</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/watch</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/incretins</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/obesity</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/type-2-diabetes</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/type-1-diabetes</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/technology</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/cardiorenal</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/masld</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/surgery</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/prevention</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/nutrition</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/pregnancy</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/children</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/topics/regulatory</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/compare/finerenone-vs-sglt2-inhibitors</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>weekly</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/compare/tirzepatide-vs-semaglutide</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>weekly</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/compare/orforglipron-vs-semaglutide</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>weekly</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/compare/retatrutide-vs-tirzepatide</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>weekly</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/compare/weekly-insulin-vs-daily-basal-insulin</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>weekly</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/compare/dapagliflozin-vs-empagliflozin</loc>
<lastmod>2026-11-17T16:37:09.477Z</lastmod>
<changefreq>weekly</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/bariatric-surgery</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/cgm</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/masld</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/metformin</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/weekly-insulins</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/oral-semaglutide</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/orforglipron</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/retatrutide</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/semaglutide</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/sglt2-inhibitors</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/hubs/tirzepatide</loc>
<lastmod>2026-10-10T05:12:34.85423+00:00</lastmod>
<changefreq>daily</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/journal-club/1</loc>
<lastmod>2026-11-13</lastmod>
<changefreq>monthly</changefreq>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/anagliptin-with-metformin-and-empagliflozin-reduces-hba1c-in-phase-iii-korean-tr</loc>
<lastmod>2026-11-17T07:48:03.748131+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/phase-3-trial-reports-bmi-changes-with-liraglutide-3-0-mg-in-children-aged-6-to-</loc>
<lastmod>2026-11-16T22:18:20.548974+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/weekly-semaglutide-lowered-bmi-in-children-aged-6-to-under-12-with-obesity-phase-687</loc>
<lastmod>2026-11-16T21:36:50.348582+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/weekly-ribupatide-lowers-body-weight-over-48-weeks-in-chinese-adults-without-dia-684</loc>
<lastmod>2026-11-16T21:36:27.441689+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/surmount-adolescents-tirzepatide-lowered-bmi-by-18-5-in-adolescents-at-72-weeks-683</loc>
<lastmod>2026-11-16T21:35:43.202223+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/cagrisema-1-7-mg-and-1-0-mg-each-cut-bodyweight-more-than-placebo-in-redefine-9</loc>
<lastmod>2026-11-16T04:45:20.873742+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/smart-insulin-pens-with-bolus-calculator-lowered-hba1c-more-than-tracking-only-p</loc>
<lastmod>2026-11-15T20:17:17.655366+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/protecting-lean-mass-on-incretins-exercise-and-trevogrumab-both-cut-loss</loc>
<lastmod>2026-11-15T02:01:33.810338+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/chmp-backs-two-insulin-aspart-biosimilars-and-issues-tirzepatide-contraceptive-a</loc>
<lastmod>2026-11-13T20:17:12.706447+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/intensive-bp-control-in-type-2-diabetes-no-significant-fall-in-dementia-or-mci</loc>
<lastmod>2026-11-13T20:02:17.601754+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/pemvidutide-in-mash-non-invasive-liver-markers-improve-at-48-weeks</loc>
<lastmod>2026-11-13T04:31:43.040033+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/trevogrumab-reduced-lean-mass-loss-on-semaglutide-in-phase-2-trial</loc>
<lastmod>2026-11-12T23:15:23.524942+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/lacto-vegetarian-diet-and-14-hour-fasting-lowered-hba1c-in-women-with-t2dm</loc>
<lastmod>2026-11-12T20:47:21.841269+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/tirzepatide-vs-intensified-care-in-early-type-2-diabetes-hba1c-results-at-week-1</loc>
<lastmod>2026-11-12T20:32:18.999967+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/guidance-on-immunotherapy-for-children-with-new-onset-stage-3-type-1-diabetes</loc>
<lastmod>2026-11-11T20:01:45.661806+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/resistance-exercise-reduced-lean-mass-loss-in-adults-on-tirzepatide-in-a-40-week</loc>
<lastmod>2026-11-10T20:32:26.68487+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/survodutide-not-linked-to-higher-cardiovascular-risk-in-phase-3-obesity-trial</loc>
<lastmod>2026-11-10T20:17:20.754163+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/efinopegdutide-improves-mash-histology-at-52-weeks-in-a-phase-2b-trial</loc>
<lastmod>2026-11-10T20:02:26.956766+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/retatrutide-eased-knee-osteoarthritis-pain-more-than-placebo-in-two-phase-3-tria</loc>
<lastmod>2026-11-09T20:32:30.023224+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/orforglipron-lowered-apnoea-hypopnoea-index-in-two-52-week-phase-3-osa-trials</loc>
<lastmod>2026-11-09T20:17:14.133722+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/fda-adds-naion-eye-warning-to-labels-of-all-glp-1-receptor-agonists</loc>
<lastmod>2026-11-09T20:02:19.984407+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/ada-2026-obesity-criteria-raise-prevalence-across-45-population-surveys</loc>
<lastmod>2026-11-06T20:02:14.236295+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/semaglutide-and-hba1c-weight-and-bp-across-ckd-stages-in-flow-post-hoc-analysis</loc>
<lastmod>2026-11-04T20:32:59.680091+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/weight-loss-not-significantly-linked-to-incretin-heart-benefit-in-meta-regressio</loc>
<lastmod>2026-11-04T20:17:09.490851+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/masld-found-in-64-9-of-1-103-adults-screened-with-fibroscan-in-chennai</loc>
<lastmod>2026-11-04T20:02:22.621962+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/real-world-cohort-sglt-2-inhibitors-linked-to-lower-kidney-failure-risk-than-glp</loc>
<lastmod>2026-11-03T20:17:15.621193+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/hypoglycaemia-linked-to-qtc-prolongation-in-type-1-and-type-2-diabetes-meta-anal</loc>
<lastmod>2026-11-03T20:02:09.742193+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/semaglutide-2-4-mg-in-obesity-related-hfpef-with-type-2-diabetes-phase-3-registr</loc>
<lastmod>2026-11-02T20:02:53.042943+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/next-generation-incretins-early-signals-beyond-semaglutide-not-yet-like-for-like</loc>
<lastmod>2026-11-01T02:03:18.256841+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/lower-gdm-diagnostic-thresholds-doubled-diagnoses-without-better-short-term-outc</loc>
<lastmod>2026-10-31T20:17:14.826072+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/oral-orforglipron-reduced-bodyweight-more-than-placebo-at-72-weeks-in-japanese-a</loc>
<lastmod>2026-10-31T20:02:33.017274+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/litmus-somasignal-panel-most-accurate-for-at-risk-mash-and-advanced-fibrosis</loc>
<lastmod>2026-10-30T20:32:46.373754+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/statstrip-gen-2-0-hospital-glucose-meter-recall-results-may-go-to-wrong-patient</loc>
<lastmod>2026-10-30T20:17:20.680306+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/cdsco-expert-committee-phase-iii-trial-of-degludec-aspart-mix-recommended</loc>
<lastmod>2026-10-30T20:02:26.360223+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/glp-1-receptor-agonists-lowered-mace-in-adults-aged-under-65-and-65-or-older</loc>
<lastmod>2026-10-28T20:02:44.105979+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/sglt2-inhibitors-in-adults-aged-75-and-over-cohort-finds-no-increased-harm-versu</loc>
<lastmod>2026-10-27T20:47:17.503841+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/fda-warns-zubb-weight-loss-supplement-contains-hidden-sildenafil</loc>
<lastmod>2026-10-27T20:32:12.77583+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/triple-agonist-ubt251-lowers-hba1c-in-chinese-adults-with-type-2-diabetes-in-pha</loc>
<lastmod>2026-10-27T20:17:18.209806+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/cagrisema-in-type-2-diabetes-meta-analysis-of-six-trials-shows-hba1c-and-weight-</loc>
<lastmod>2026-10-27T20:02:43.895613+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/glp-1-ra-use-and-neuropsychiatric-outcomes-in-medicare-adults-with-type-2-diabet</loc>
<lastmod>2026-10-26T20:02:21.689062+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/sglt2-inhibitor-use-associated-with-small-rises-in-haemoglobin-and-haematocrit-8</loc>
<lastmod>2026-10-25T20:02:40.396633+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/oral-glp-1-agonists-early-hba1c-data-regulators-acting-safety-data-still-missing</loc>
<lastmod>2026-10-25T02:03:07.359592+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/fda-approves-once-weekly-insulin-awiqli-for-children-with-type-2-diabetes</loc>
<lastmod>2026-10-23T20:32:11.115975+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/retatrutide-cut-sleep-apnoea-severity-more-than-placebo-in-two-phase-3-trials</loc>
<lastmod>2026-10-23T20:17:48.717853+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/cdsco-expert-committee-trial-permission-recommended-for-oral-semaglutide-3-more</loc>
<lastmod>2026-10-23T20:02:00.346224+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/diabetes-duration-and-insulin-use-predicted-remission-in-armms-t2d</loc>
<lastmod>2026-10-21T20:32:29.269012+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/semaglutide-safety-by-egfr-in-flow-fewer-serious-adverse-events-than-placebo</loc>
<lastmod>2026-10-21T20:17:35.649639+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/cdsco-expert-committee-virchow-liraglutide-and-roche-petrelintide-trials</loc>
<lastmod>2026-10-21T20:01:55.786106+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/degludec-linked-to-lower-all-cause-mortality-than-glargine-in-swedish-register</loc>
<lastmod>2026-10-20T20:47:21.196851+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/fda-flags-most-serious-recall-of-nova-statstrip-gen-2-0-hospital-glucose-meters</loc>
<lastmod>2026-10-20T20:32:17.430902+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/carotid-plaque-linked-to-later-cardiovascular-events-in-adults-with-type-1-diabe</loc>
<lastmod>2026-10-20T20:17:17.987145+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/smart-mdi-non-inferior-to-mdi-plus-cgm-in-type-1-diabetes-with-hba1c-of-8-or-mor</loc>
<lastmod>2026-10-20T20:02:18.812562+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/oral-glp-1-drugs-a-committee-opinion-registry-numbers-and-an-early-phase-ii-sign</loc>
<lastmod>2026-10-18T05:26:54.051236+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/oral-glp-1-agonist-hrs-7535-lowered-hba1c-in-phase-ii-trial-in-type-2-diabetes</loc>
<lastmod>2026-10-18T05:01:02.722022+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/cgm-lowers-hba1c-in-adults-with-type-2-diabetes-not-using-insulin-in-primary-car</loc>
<lastmod>2026-10-18T04:45:42.884633+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/ema-committee-backs-orforglipron-foundayo-for-weight-management-and-type-2-diabe</loc>
<lastmod>2026-10-18T04:30:41.901723+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/oral-orforglipron-vs-dapagliflozin-on-metformin-achieve-2-hba1c-results-posted</loc>
<lastmod>2026-10-18T04:15:55.698835+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/type-1-diabetes-linked-to-higher-mortality-with-a-larger-relative-gap-in-females</loc>
<lastmod>2026-10-15T20:17:09.874016+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/indian-moderate-carbohydrate-diet-plus-exercise-60-9-estimated-remission-in-earl</loc>
<lastmod>2026-10-15T20:02:19.506512+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/cdsco-expert-committee-no-phase-iii-waiver-for-alkem-semaglutide</loc>
<lastmod>2026-10-15T02:20:21.652324+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/tirzepatide-lowered-hscrp-and-nt-probnp-in-a-meta-analysis-of-seven-studies</loc>
<lastmod>2026-10-14T20:03:59.849207+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/network-meta-analysis-sglt2-inhibitors-versus-finerenone-in-ckd-with-type-2-diab</loc>
<lastmod>2026-10-13T20:03:56.190691+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/meta-analysis-sglt2-inhibitors-reduce-heart-failure-or-cv-death-in-type-2-diabet</loc>
<lastmod>2026-10-13T20:02:18.237942+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/the-next-wave-of-glp-1-drugs-early-promise-but-cost-and-access-still-unclear</loc>
<lastmod>2026-10-11T14:01:46.477605+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/orforglipron-with-insulin-glargine-larger-hba1c-fall-than-placebo-in-phase-3</loc>
<lastmod>2026-10-11T13:52:31.654737+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/twiist-automated-insulin-delivery-in-type-2-diabetes-13-week-single-arm-trial</loc>
<lastmod>2026-10-11T13:53:15.727713+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/semaglutide-in-diabetic-kidney-disease-primary-mri-outcomes-not-met-in-52-week-t</loc>
<lastmod>2026-10-10T05:36:22.551567+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/ada-and-easd-2026-consensus-earlier-sglt2-inhibitor-or-glp-1-use-in-type-2-diabe</loc>
<lastmod>2026-10-11T14:03:35.931756+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/resmetirom-effects-in-mash-were-similar-across-common-risk-genotypes</loc>
<lastmod>2026-10-11T13:57:43.579911+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/oral-safiglipron-versus-dapagliflozin-in-type-2-diabetes-phase-3-trial-in-china</loc>
<lastmod>2026-10-11T13:58:23.952713+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/chemically-synthesised-semaglutide-hd1916-matches-wegovy-for-weight-loss-in-chin</loc>
<lastmod>2026-10-11T14:04:21.413882+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/nearly-one-in-four-indigenous-adults-in-odisha-had-impaired-kidney-function-in-a</loc>
<lastmod>2026-10-11T13:59:49.276317+00:00</lastmod>
</url>
<url>
<loc>https://www.diabesityrounds.com/a/triple-agonist-ubt251-lowered-body-weight-over-24-weeks-in-a-phase-2-trial</loc>
<lastmod>2026-10-11T13:47:40.772746+00:00</lastmod>
</url>
</urlset>
